Structure-based drug design of novel inhibitors of carbonic anhydrase for treatment of glaucoma

No Thumbnail Available
File version
Author(s)
Paul, Blessy
Singer, Mathilde
Lopez, Marie
Poulsen, Sally-Ann
Hofmann, Andreas
Primary Supervisor
Other Supervisors
Editor(s)
Date
2009
Size
File type(s)
Location
Barossa Valley, South Australia
License
Abstract

In humans, there are twelve carbonic anhydrase (CA) isozymes that possess catalytic activity for the reversible hydration of carbon dioxide. Carbonic anhydrases (CAs) underpin crucial physiological and pathological processes and are thus pharmaceutical targets for a variety of diseases, including glaucoma (CAII). Aromatic sulfonamides are the classical small molecule CA inhibitors and act through coordination of the sulfonamide anion (Ar-SO2NH-) to the active site zinc cation, replacing the zinc-bound hydroxyl anion, thereby impeding the endogenous reaction.

Journal Title
Conference Title
Structure-based drug design of novel inhibitors of carbonic anhydrase for treatment of glaucoma
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Structural Chemistry and Spectroscopy
Persistent link to this record
Citation